Delivery Order SPE2DB20D2104-SPE2DB25FMJSE

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,103.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/mL SureClick, a specialty medication used for cardiovascular health. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $43,022.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and covers the supply of Repatha 140 mg/ml SureClick medication. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $19,652.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick medication, a specialty pharmaceutical product used to treat cardiovascular conditions. The award is a delivery order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $16,178.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/mL SureClick, a medication used to treat high cholesterol. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
The federal contract award was granted by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,975.58 firm-fixed-price delivery order is for the supply of Repatha 140 mg/ml SureClick medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $11,030.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Repatha 140 mg/mL SureClick, a specialty medication used for cardiovascular health. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award, valued at $6,383.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Repatha 140 mg/ml SureClick medication. The contract has a firm fixed price and an ultimate completion date of November 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, with a ceiling value of $1,694.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick medication. The award is a delivery order and the pricing type is firm fixed price. The contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $14,990.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha 140 mg/ml SureClick medication, a specialty pharmaceutical product used for cardiovascular health. This is a delivery order contract with a firm-fixed price pricing type, and the ultimate completion date is November 12, 2024. The contract award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,743.87, is for the delivery of Repatha 140 mg/mL SureClick medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMJSE
    Delivery Order

This federal contract award, valued at $1,577.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/mL SureClick medication, a cardiovascular treatment.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:48 AM